Abstract
The increasing medicinal use of cannabis during recent years has largely overlooked children and pregnant women due to litigious and ethical concerns. However, over the last few years medicine has observed increasing numbers of children treated with cannabis for autism spectrum disorder (ASD) and fetal alcohol spectrum disorder (FASD), and pregnant women treated for hyperemesis gravidarum (HG). This review provides an account of major findings discovered through this research. Specifically, cannabis may offer therapeutic advantages to behavioral symptoms of autism spectrum disorder and fetal alcohol spectrum disorder, and to the severe nausea and vomiting in hyperemesis gravidarum. The use of medical cannabis in children and pregnant women should be further discussed and researched in this patient population.
Highlights
The increasing medicinal use of cannabis during cerns.[1]
Over the last few years we have become active observers of the increasing number of children treated with cannabis for autism spectrum disorder (ASD) and fetal alcohol spectrum disorder (FASD), and pregnant women treated for hyperemesis gravidarum (HG)
When parents (51 out of 53) were asked to evaluate the overall change in their children’s ASD symptoms, significant improvement was reported in 43.1%, mild to moderate improvement was reported in 31.4%, and no change was reported in 21.6%; in the case of 2 children (3.9%), parents reported a worsening of symptoms
Summary
The increasing medicinal use of cannabis during cerns.[1]. Unlike with medicinal drugs which have clear recent years has largely overlooked children and chemical, pharmacokinetic, and pharmacodynamic pregnant women due to litigious and ethical con- properties, one cannot be sure how much cannabis. Outside the realm of well researched medical practice, pregnant women and parents with special-needs children often feel that their medical needs and those of their children are not met with conventional medicine This has led an increasing number of parents to take the initiative and offer cannabis to their loved ones. Over the last few years we have become active observers of the increasing number of children treated with cannabis for autism spectrum disorder (ASD) and fetal alcohol spectrum disorder (FASD), and pregnant women treated for hyperemesis gravidarum (HG) This narrative review provides an account of our main findings from these preliminary observations, supported by searches of the PubMed, Embase®, and Cochrane databases up to July 2019
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
